Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07288359 |
| Title | Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Tennessee Oncology PLLC | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
| Novartis Investigative Site | RECRUITING | Kyoto | 6068507 | Japan | Details | |
| Novartis Investigative Site | RECRUITING | Singapore | 168583 | Singapore | Details | |
| Novartis Investigative Site | RECRUITING | Taipei | 10002 | Taiwan | Details |